Oregon DUR Newsletter

The Drug Use Review Newsletters are now available online in two formats:

• The PDF files are scanned reproductions of the print version of the newsletter. To view or print a PDF file requires Acrobat Reader, which is free to download. When you have completed downloading Acrobat Reader, use the "Back" feature on your browser to return here. The PDF versions of newsletters are 2 to 8 pages long and 1-5 MB in size.
• The newsletters are also available in HTML format. These copies are viewable in your browser and are complete articles, however they lack the formatting of the original newsletters.

Volume 6 - 2004
Issue		Table of Contents		PDF
No. 8, Sept. 2004		Off-Label Use of Modafinil (Provigil®)
No. 7, August 2004		Three New Classes Added to OHP Drug List
No. 6, July 2004		Hepatitis C: Recommendations for Antiviral Therapy
No. 5, June 2004		Atypical Antipsychotics and Metabolic Abnormalities
No. 4, April 2004		Two New Drug Review Programs Set to Start in May
No. 3, March 2004		Use of Selective Serotonin Reuptake Inhibitors in Pediatric Patients
No. 2, February 2004		Prilosec OTC Offers Exceptional Value for PPI Therapy
No. 1, January 2004		Oregon Alliance Working for Antibiotic Resistance Education (AWARE)

Copyright 2006
Oregon State University
All Rights Reserved

Oregon State University grants permission to use this newsletter for noncommercial educational and research purposes only. The copyright and this grant of permission do not allow the use of the name of Oregon State University to be used in any advertising or publicity pertaining to the use of this newsletter without specific written prior authorization from the OSU College of Pharmacy.